TY - JOUR
KW - addiction treatment
KW - buprenorphine
KW - Correctional facility
KW - Jail
KW - opioid agonist treatment
KW - opioid use disorder
KW - Prison
AU - L. Regenstreif
AU - M. Sadik
AU - E. Beaulieu
AU - C. Bodkin
AU - L. Kiefer
AU - D. Guenter
AU - P. W. P. Lee
AU - F. G. Kouyoumdjian
A1 - 
AD - Department of Family Medicine, McMaster University, 100 Main Street West, 5th Floor, Hamilton, ON, L8P 1H6, Canada.; Department of Family Medicine, McMaster University, 100 Main Street West, 5th Floor, Hamilton, ON, L8P 1H6, Canada.; Department of Family Medicine, McMaster University, 100 Main Street West, 5th Floor, Hamilton, ON, L8P 1H6, Canada.; Department of Family Medicine, McMaster University, 100 Main Street West, 5th Floor, Hamilton, ON, L8P 1H6, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Ontario Ministry of the Solicitor General, Toronto, Ontario, Canada.; Department of Family Medicine, McMaster University, 100 Main Street West, 5th Floor, Hamilton, ON, L8P 1H6, Canada.; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Family Medicine, McMaster University, 100 Main Street West, 5th Floor, Hamilton, ON, L8P 1H6, Canada. kouyouf@mcmaster.ca.
BT - Health & justice
C5 - Education & Workforce; Opioids & Substance Use
CP - 1
DO - 10.1186/s40352-022-00174-w
IS - 1
JF - Health & justice
LA - eng
M1 - Journal Article
PY - 2022
SN - 2194-7899; 2194-7899; 2194-7899
SP - 11
T1 - Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
T2 - Health & justice
TI - Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
U1 - Education & Workforce; Opioids & Substance Use
U2 - 35235073
U3 - 10.1186/s40352-022-00174-w
VL - 10
VO - 2194-7899; 2194-7899; 2194-7899
Y1 - 2022
Y2 - Mar 2
ER -